203 related articles for article (PubMed ID: 18457896)
1. A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides.
Park K; Hong HY; Moon HJ; Lee BH; Kim IS; Kwon IC; Rhee K
J Control Release; 2008 Jun; 128(3):217-23. PubMed ID: 18457896
[TBL] [Abstract][Full Text] [Related]
2. Identification of a peptide ligand recognizing dysfunctional endothelial cells for targeting atherosclerosis.
Thapa N; Hong HY; Sangeetha P; Kim IS; Yoo J; Rhee K; Oh GT; Kwon IC; Lee BH
J Control Release; 2008 Oct; 131(1):27-33. PubMed ID: 18680772
[TBL] [Abstract][Full Text] [Related]
3. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
4. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
Kim JH; Kim YS; Kim S; Park JH; Kim K; Choi K; Chung H; Jeong SY; Park RW; Kim IS; Kwon IC
J Control Release; 2006 Mar; 111(1-2):228-34. PubMed ID: 16458988
[TBL] [Abstract][Full Text] [Related]
5. Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery.
Yoo HS; Lee JE; Chung H; Kwon IC; Jeong SY
J Control Release; 2005 Mar; 103(1):235-43. PubMed ID: 15710514
[TBL] [Abstract][Full Text] [Related]
6. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
7. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles.
Nam HY; Kwon SM; Chung H; Lee SY; Kwon SH; Jeon H; Kim Y; Park JH; Kim J; Her S; Oh YK; Kwon IC; Kim K; Jeong SY
J Control Release; 2009 May; 135(3):259-67. PubMed ID: 19331853
[TBL] [Abstract][Full Text] [Related]
8. Cellular uptake pathway and drug release characteristics of drug-encapsulated glycol chitosan nanoparticles in live cells.
Park S; Lee SJ; Chung H; Her S; Choi Y; Kim K; Choi K; Kwon IC
Microsc Res Tech; 2010 Sep; 73(9):857-65. PubMed ID: 20232459
[TBL] [Abstract][Full Text] [Related]
9. In vivo quantitative measurement of arthritis activity based on hydrophobically modified glycol chitosan in inflammatory arthritis: more active than passive accumulation.
Park KS; Kang JH; Sa KH; Koo HB; Cho HJ; Nam EJ; Youn IC; Kim KM; Kim IS; Kwon IC; Choi KW; Kang YM
Mol Imaging; 2012; 11(5):389-400. PubMed ID: 22954183
[TBL] [Abstract][Full Text] [Related]
10. Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging.
Nam T; Park S; Lee SY; Park K; Choi K; Song IC; Han MH; Leary JJ; Yuk SA; Kwon IC; Kim K; Jeong SY
Bioconjug Chem; 2010 Apr; 21(4):578-82. PubMed ID: 20201550
[TBL] [Abstract][Full Text] [Related]
11. Molecular targeting of atherosclerotic plaques by a stabilin-2-specific peptide ligand.
Lee GY; Kim JH; Oh GT; Lee BH; Kwon IC; Kim IS
J Control Release; 2011 Oct; 155(2):211-7. PubMed ID: 21781994
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an alphavbeta3 integrin-targeted fluorochrome.
Waldeck J; Häger F; Höltke C; Lanckohr C; von Wallbrunn A; Torsello G; Heindel W; Theilmeier G; Schäfers M; Bremer C
J Nucl Med; 2008 Nov; 49(11):1845-51. PubMed ID: 18927332
[TBL] [Abstract][Full Text] [Related]
13. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles.
Park K; Kim JH; Nam YS; Lee S; Nam HY; Kim K; Park JH; Kim IS; Choi K; Kim SY; Kwon IC
J Control Release; 2007 Oct; 122(3):305-14. PubMed ID: 17643545
[TBL] [Abstract][Full Text] [Related]
14. MR and fluorescent imaging of low-density lipoprotein receptors.
Li H; Gray BD; Corbin I; Lebherz C; Choi H; Lund-Katz S; Wilson JM; Glickson JD; Zhou R
Acad Radiol; 2004 Nov; 11(11):1251-9. PubMed ID: 15561572
[TBL] [Abstract][Full Text] [Related]
15. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle.
Kelly KA; Allport JR; Tsourkas A; Shinde-Patil VR; Josephson L; Weissleder R
Circ Res; 2005 Feb; 96(3):327-36. PubMed ID: 15653572
[TBL] [Abstract][Full Text] [Related]
16. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice.
Chen K; Yap LP; Park R; Hui X; Wu K; Fan D; Chen X; Conti PS
Amino Acids; 2012 Apr; 42(4):1329-37. PubMed ID: 21212998
[TBL] [Abstract][Full Text] [Related]
17. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
[TBL] [Abstract][Full Text] [Related]
18. Oleyl-chitosan nanoparticles based on a dual probe for optical/MR imaging in vivo.
Lee CM; Jang D; Kim J; Cheong SJ; Kim EM; Jeong MH; Kim SH; Kim DW; Lim ST; Sohn MH; Jeong YY; Jeong HJ
Bioconjug Chem; 2011 Feb; 22(2):186-92. PubMed ID: 21243999
[TBL] [Abstract][Full Text] [Related]
19. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
Xanthoulea S; Gijbels MJ; van der Made I; Mujcic H; Thelen M; Vergouwe MN; Ambagts MH; Hofker MH; de Winther MP
Cardiovasc Res; 2008 Nov; 80(2):309-18. PubMed ID: 18628255
[TBL] [Abstract][Full Text] [Related]
20. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.
Wang Y; Zhao X; Jin H; Wei H; Li W; Bu D; Tang X; Ren Y; Tang C; Du J
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):173-9. PubMed ID: 18988885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
